Related Experiment Video
Updated: Jan 25, 2026

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
Published on: May 24, 2016
Modeling cardiac complexity: Advancements in myocardial models and analytical techniques for physiological
Insights
This review explores in vitro cardiomyocyte models and advanced techniques for studying heart conditions like cardiomyopathies and heart failure. It aids researchers in understanding cardiomyocyte function for better disease modeling and therapeutic development.
Area of Science:
- Cardiovascular Biology
- Biomedical Engineering
- Translational Medicine
Background:
- Cardiomyopathies, heart failure, and arrhythmias affect millions globally, leading to sudden cardiac death and reduced quality of life.
- Cardiomyocyte dysfunction underlies these conditions, making them critical targets for fundamental research, drug discovery, and tissue engineering.
- Effective in vitro myocardial models and experimental techniques are essential for investigating cardiomyocyte physiology.
Purpose of the Study:
- To provide a comprehensive review of in vitro cardiomyocyte models and disease modeling strategies.
- To highlight advancements in techniques for characterizing cardiomyocyte physiology.
- To offer a biological framework for engineers and technical insights for biologists in the field.
Main Methods:
- Exploration of diverse cell models and tissue constructs for basic and translational research.
- Review of cutting-edge imaging, electrophysiology, metabolic, and mechanical characterization modalities.
- Analysis of the technical basis and limitations of physiological measurement techniques.
Main Results:
- Detailed overview of current in vitro myocardial models and disease modeling approaches.
- Identification of recent technological advancements enhancing the study of cardiomyocyte function.
- Synthesis of information bridging engineering and biological perspectives in cardiac research.
Conclusions:
- In vitro cardiomyocyte models are crucial for advancing our understanding of cardiovascular diseases.
- State-of-the-art measurement modalities offer powerful tools for physiological investigation.
- This review facilitates interdisciplinary collaboration in cardiac research and therapeutic development.
Abstract:
Cardiomyopathies, heart failure, and arrhythmias or conduction blockages impact millions of patients worldwide and are associated with marked increases in sudden cardiac death, decline in the quality of life, and the induction of secondary pathologies. These pathologies stem from dysfunction in the contractile or conductive properties of the cardiomyocyte, which as a result is a focus of fundamental investigation, drug discovery and therapeutic development, and tissue engineering. All of these foci require in vitro myocardial models and experimental techniques to probe the physiological functions of the cardiomyocyte. In this review, we provide a detailed exploration of different cell models, disease modeling strategies, and tissue constructs used from basic to translational research. Furthermore, we highlight recent advancements in imaging, electrophysiology, metabolic measurements, and mechanical and contractile characterization modalities that are advancing our understanding of cardiomyocyte physiology. With this review, we aim to both provide a biological framework for engineers contributing to the field and demonstrate the technical basis and limitations underlying physiological measurement modalities for biologists attempting to take advantage of these state-of-the-art techniques.
Related Concept Videos
Development of Analytical Methods
Clearance Models: Physiological Models
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiology of the Heart: The Cardiac Cycle
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Physiological Pharmacokinetic Models: Assumption with Protein Binding

